TOP > News >
Investigator-initiated clinical trial to be started at Northwestern University as one of our U.S. initiatives for the treatment (RS5614) of lung injuries associated with COVID-19 infections (ClinicalTrials.gov: NCT04634799).
Investigator-initiated clinical trial to be started at Northwestern University as one of our U.S. initiatives for the treatment (RS5614) of lung injuries associated with COVID-19 infections (ClinicalTrials.gov: NCT04634799).
Click here to read the National Institute of Health’s (HIN) National Library of Medicine clinical trials database registry.
Click herefor more information on our COVID-19 therapeutic candidate development project(RS5614).
